Imunon, Inc.
Pharmaceutical Preparations · Lawrenceville, NJ, United States
- PrincipalsDouglas Vincent FallerChief Medical OfficerJeffrey Wayne ChurchCFOKhursheed AnwerChief Scientific Officerand 8 more
- CompanyImunon, Inc.Lawrenceville, NJ, United States
- Phone line+1 (609) 896-9100General business
Imunon, Inc. is an SEC-registered Nasdaq-listed company (ticker IMNN) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 11
Chief executive
Stacy LindborgPresident and CEO
Chair & board
Christine A PellizzariDirector (Board)
Donald P BraunDirector (Board)
Frederick J. FritzDirector (Board)
James E DentzerDirector (Board)
Legal
Susan EylwardGeneral Counsel and Corp Sec
Everyone else on file (2)
Douglas Vincent FallerChief Medical Officer
Khursheed AnwerChief Scientific Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Jeffrey Wayne Church — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Douglas Vincent Faller — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Khursheed Anwer — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Kimberly Bragg — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Incannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capability